DEVELOPING IN-HOUSE, POINT-OF-CARE MANUFACTURED ANTI-CD19 CHIMAERIC ANTIGEN RECEPTOR (CAR)-T CELLS

被引：0
|
作者：
Chan, Nelson Chun Ngai [1 ,2 ]
Loaiza, Sandra [1 ,2 ]
Uddin, Shab [1 ,2 ]
Aina, Edward [1 ,2 ]
Cook, Lucy [3 ]
Palanicawandar, Renuka
Bara, Anna [4 ]
Olavarria, Eduardo [3 ]
Apperley, Jane [3 ]
Karadimitris, Anastasios [3 ]
机构：
[1] Imperial Coll Healthcare NHS Trust, John Goldman Ctr Cellular Therapies, London, England
[2] Imperial Coll Healthcare NHS Trust, London, England
[3] Imperial Coll London, Ctr Haematol, London, England
[4] Natl Inst Hlth Res Imperial Clin Res Facil, London, England
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P085
引用
收藏
页码：209 / 210
页数：2
相关论文
共 50 条
  • [1] Feasibility of point-of-care manufactured anti-CD19 CAR-T cells (SiCF-019) for relapsed/refractory B cell malignancies
    Luanpitpong, Sudjit
    Klaihmon, Phatchanat
    Janan, Montira
    Kungwankiattichai, Smith
    Owattanapanich, Weerapat
    Issaragrisil, Surapol
    CANCER SCIENCE, 2025, 116 : 1213 - 1213
  • [2] Point-of-care anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory follicular lymphoma
    Fried, Shalev
    Shkury, Eden
    Itzhaki, Orit
    Sdayoor, Inbal
    Yerushalmi, Ronit
    Shem-Tov, Noga
    Danylesko, Ivetta
    Jacoby, Elad
    Shouval, Roni
    Kedmi, Meirav
    Marcus, Ronit
    Nagler, Arnon
    Shimoni, Avichai
    Avigdor, Abraham
    LEUKEMIA & LYMPHOMA, 2023, 64 (12) : 1956 - 1963
  • [3] Media evaluation for production and expansion of anti-CD19 chimeric antigen receptor (CAR) T cells
    Alnabhan, Rehab
    Magalhaes, Isabelle
    Mattson, Jonas
    Uhlin, Michael
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2017, 86 (04) : 332 - 332
  • [4] Development and in vivo evaluation of anti-CD19 chimeric antigen receptor (CAR) -yδt cells
    Kim, Nayoung
    Kim, Hyery
    Im, Ho Joon
    Koh, Kyung-Nam
    TISSUE ENGINEERING PART A, 2022, 28 : 278 - 278
  • [5] Anti-CD19 CAR T-cells
    Smith, Lan-Lan
    LANCET ONCOLOGY, 2017, 18 (01): : 26 - 26
  • [6] Point-of-care manufacturing of anti-CD19 CAR-T cells using a closed production platform: Experiences of an academic in Thailand
    Luanpitpong, Sudjit
    Klaihmon, Phatchanat
    Janan, Montira
    Kungwankiattichai, Smith
    Owattanapanich, Weerapat
    Kunacheewa, Chutima
    Chanthateyanonth, Supasorn
    Donsakul, Nawapotch
    U-pratya, Yaowalak
    Warindpong, Thanatphak
    Kittivorapart, Janejira
    Permpikul, Parichart
    Issaragrisil, Surapol
    MOLECULAR THERAPY ONCOLOGY, 2024, 32 (04):
  • [7] Point-of-care anti-CD19 CAR T-cells for treatment of relapsed and refractory aggressive B-cell lymphoma
    Kedmi, Meirav
    Shouval, Roni
    Fried, Shalev
    Bomze, David
    Fein, Joshua
    Cohen, Zachary
    Danilesko, Ivetta
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Jacoby, Elad
    Besser, Michal
    Shimoni, Avichai
    Nagler, Arnon
    Avigdor, Abraham
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (05): : 251 - 257
  • [8] Biomarker analysis of patients treated with anti-CD19 chimeric antigen receptor (CAR) T cells.
    Bot, Adrian
    Kochenderfer, James
    Mardiros, Armen
    Perez, Arianne
    Navale, Lynn
    Chang, Richard
    Yueh Wei-Shen
    Yoder, Sean
    Jia Xiao-Chi
    Rosenberg, Steven A.
    Go, William Y.
    Wiezorek, Jeffrey S.
    Roberts, Margo
    Chang, David D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] PHASE 1 CLINICAL TRIAL OF CD19 CAR-T CELLS MANUFACTURED AT THE POINT-OF-CARE
    Hutchins, C. J.
    Henderson, A.
    Lynam, E. C.
    Abaca-Cleopas, M.
    Harvey, K. J.
    Acworth, M. C.
    Leung, C.
    Barnes, E.
    Robb, R. J.
    Mudie, K.
    O'Donnell, M.
    Perera, N.
    Pillai, E. Subramonia
    Curley, C.
    Henden, A.
    Kennedy, G.
    Tey, S.
    CYTOTHERAPY, 2023, 25 (06) : S229 - S229
  • [10] Clinical Results of a First-in-Human Phase 1 Study of Point-of-Care Manufactured Bispecific Anti-CD19, Anti-CD20 Chimeric Antigen Receptor Modified T (CAR-20.19-T) Cells for Relapsed, Refractory, Non-Hodgkin Lymphoma (NHL)
    Shah, Nirav N.
    Zhu, Fenlu
    Keever-Taylor, Carolyn
    Schneider, Dina
    Kruger, Winfred
    Worden, Andrew
    Hamadani, Mehdi
    Fenske, Timothy S.
    Johnson, Bryon D.
    Dropulic, Boro
    Orentas, Rimas
    Hari, Parameswaran
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
12345